周菲菲

一、导师基本情况

1.中医妇科学，硕士，副主任医师，硕士生导师

2.邮箱：5510025@zju.edu.cn

3.指导专业：中医妇科、妇产科、生殖免疫

二、研究领域

生殖免疫

三、教育和工作经历

1.教育经历：

2003/09-2010/06，浙江中医药大学第一临床医学院，七年制中医学，获得硕士学位，导师：傅萍教授；

2.工作经历：

2021/04-至今，浙江省人民医院，中西医结合生殖免疫科，副主任医师；

2013/07-2021/04，浙江大学医学院附属妇产科医院，中医科，主治医师；

2010/07-2013/07，浙江大学医学院附属妇产科医院，中医科，住院医师；

四、学术任职

1.中国中医药研究促进会妇科流派分会委员

2.中国人体健康科技促进会生殖免疫专业委员会常务委员

3.中国优生优育协会生育力保护与修复专业委员会常务委员

4.中国民族医药学会妇科分会青年委员会常务委员

5.浙江省妇幼保健协会生殖免疫专委会副主委

6.浙江省康复医学会生殖专业委员会委员

7.浙江省数理医学学会女性盆底功能障碍性疾病研究中心委员

8.浙江省预防医学会妇科治未病专委会委员

五、主持教学科研项目

1.国家中医药管理局科技司-浙江省共建项目，GZY-ZJ-KJ-24010，封闭抗体低下型同种免疫紊乱复发性流产中药制剂的开发应用，2024.1-2026.12，30万，在研，主持；

2.教育部产学合作协同育人项目2022年第一批立项项目，220400576290837，中医妇科大数据临床研究方法教学，2022.10-2024.10，5万，已验收，主持；

3.浙江省中医药重点项目研究，2018ZZ017，加味补中益气汤对成纤维细胞功能紊乱介导的绝经后压力性尿失禁的调节作用及机制研究，2017.9-2020.9，15万元，已验收，主参；

4.浙江省中医药科技计划，2017ZA090，傅萍名中医调经助孕安胎经验整理及研究，2016.10.1-2018.12.31，3万元，已验收，主持；

六、代表性论著

1.Wang Yuhan; Chen Yijie; Ma Xiaofang; Guan Jili; Gao Yang; Hong Xuezi; Fu Ping;Zhou Feifei; Apo E protein and related markers show the prognosis of stress urinary incontinence rats treated with modified Buzhong Yiqi decoction, International Journal of Biological Macromolecules, 2024, 280: 135996 (唯一通讯作者)

2.Zhao Kun; Xu Junmiao; Zhao Jingting; Chen Rongrong; Wang Yuhan; Ye Xiangming; Zhou Feifei; Influence of prenatal aquatic activities on fetal outcomes and maternal physical and mental outcomes: a systematic review and meta-analysis, Bmc Pregnancy and Childbirth, 2024,24(1): 701 (共同通讯作者)

3.Zixing Zhong；Qingmei Yang；Chu Li；Xiaohong Chen；Feifei Zhou；A Global Perspective of Correlation Between Maternal Blood Lead Levels and Risks of Preeclampsia: An Updated Systematic Review and Meta-analysis，Frontiers in Public Health，2022 Dec 23;10:1072052.(唯一通讯作者)

4.Hua Nanni; Chen Anxian; Chen Yang; Dong Hui; He Xianglei; Ru Guoqing; Tong Xiangmin; Zhou Feifei; Wang Shibing ; The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma, Molecular Biology Reports, 2022,49(8):7911-7919 (共同通讯作者)

5.Feifei Zhou*; Chen Chen; Jiani Shi; Qianru Zhou; Lijun Jin; Xiaofang Ma; Clinical Study on the Treatment of Female Stress Urinary Incontinence with Modified Buzhong Yiqi Decoction, Frontiers in Surgery, 2022,9:882621(唯一第一作者)

6.Zixing Zhong; Yuhan Wang; Guiqin Wang; Feifei Zhou*; Case report:TNF-alpha inhibitors to rescue pregnancy in women with potential pregnancy loss: A report of ten cases, Frontiers in Immunology, 2022,13：900537(唯一通讯作者 )

7.Luyang Wang; Hairui Wang; Chen Yang; Yunyi Wu; Guojie Lei; Yanhua Yu; Yan Gao; Jing Du; Xiangmin Tong; Feifei Zhou*; Yanchun Li; Ying Wang; Investigating CENPW as a Novel Biomarker Correlated With the Development and Poor Prognosis of Breast Carcinoma, Frontiers in Genetics, 2022, 13：900111.(共同通讯作者)

8.Ning Zhu; Xiaohong Chen; Junjun Zhao; Lijuan Fang; Yingmin Yao; Feifei Zhou*; Liang Tao; Qiuran Xu; Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway, Journal of Cancer, 2022, 13:3177-3188.(共同通讯作者)

9.Feifei Zhou*; Jiang Ruoan; Liang Ruojia; Yu Luo; Jiang Nan; Jiamin Luo; Xiufeng Huang; The clinical significance of prethrombotic state t-PA, PAl-l, and D-dimer data in the diagnosis and treatment of recurrent abortion in pregnant Chinese women，International Journal Of Clinical And Experimental Medicine，2019，12(12)：13230-13243.(唯一第一作者)

10.Feifei Zhou, Huimin Zhu，Xiaoyan Sun, etc. One-year follow-up to evaluate the therapeutic value of Jiawei Bu-Zhong-Yi-Qi decoction on women with stress urinary incontinence[J]. Basic & Clinical Pharmacology & Toxicology, AUG 2019(299):179-180(共同第一作者)